PMDA drug package insert
カルバゾクロムスルホン酸Na静注25mg「フソー」
PMDA Prescription drug · 扶桑薬品工業株式会社 · package insert Oct 1, 2026
Key facts
| Brand names | カルバゾクロムスルホン酸Na静注25mg「フソー」, カルバゾクロムスルホン酸Na静注50mg「フソー」, カルバゾクロムスルホン酸Na静注100mg「フソー」 |
|---|---|
| Nonproprietary names | カルバゾクロムスルホン酸ナトリウム水和物 |
| Companies | 製造販売元／扶桑薬品工業株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 止血剤 |
| Therapeutic category codes | 873321 |
| YJ codes | 3321401A2189, 3321401A3193, 3321401A4262 |
| Approval numbers | 23000AMX00522, 23000AMX00523, 23000AMX00524 |
| Package insert edition | 第3版 |
| Package insert date | Oct 1, 2026 |
| PMDA document key | 670156_3321401A2189_1 |
| PMDA company code | 670156 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: